For instance, in other solid cancers, such as melanoma and clear cell renal cell carcinoma, it has been shown that alterations of genes encoding modifiers of the SWI/SNF chromatin remodeling complex such as PBRM1, ARID2 and BRD7 could be associated with response to therapy with immune checkpoint inhibitors (ICIs), cellular-based vaccines or adoptive T cell therapies [7,8]. This evidence concerns the gene SMARCA1 and clear cell renal carcinoma.